PANACEA
Within PANACEA we will use C. elegans to address the following two key questions: 1) how the genetic background affects complex disease signaling pathways and 2) whether we can predict the effect of the genetic background on these pathways.
About usPANACEA
Quantitative pathway analysis of natural variation in complex disease signaling in C. elegans (PANACEA). EU, 7th Framework Programme, Period: 2009-2012
Continue to
